Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.38 |
| ▸ | GALR3 | O60755 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30683844 | 0.98 | ALDH1A1 (0.40) | LMNAALDH1A1HSD17B10TSHRCYP1A2 | |
| SCHEMBL7186589 | 0.90 | LMNA (0.34) | LMNAALDH1A1HSD17B10TSHRCYP1A2 | |
| SCHEMBL8448704 | 0.88 | ALDH1A1 (0.43) | LMNAALDH1A1HSD17B10TSHRSMN1; SMN2 | |
| SCHEMBL18134200 | 0.88 | ALDH1A1 (0.43) | LMNAALDH1A1HSD17B10TSHRSMN1; SMN2 | |
| SCHEMBL11376586 | 0.88 | LMNA (0.33) | LMNAALDH1A1HSD17B10TSHRCYP1A2 | |
| SCHEMBL31196271 | 0.83 | ALDH1A1 (0.36) | LMNAALDH1A1HSD17B10GALR3 | |
| SCHEMBL9214255 | 0.82 | USP2 (0.33) | LMNAALDH1A1TSHRCYP1A2SMN1; SMN2 | |
| SCHEMBL7608822 | 0.80 | ALDH1A1 (0.37) | LMNAALDH1A1HSD17B10TSHRCYP1A2 | |
| SCHEMBL13034076 | 0.79 | ALDH1A1 (0.38) | LMNAALDH1A1HSD17B10TSHR | |
| SCHEMBL622706 | 0.79 | TSHR (0.42) | LMNAALDH1A1TSHRCYP1A2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1090902-A2 | Method for producing alcohols such as cyclohexanedimethanol | Nippon Shokubai Co., Ltd. (JP) | 2001-04-11 | — | — | EP | claimed |
| CN-111065700-B | Cationic electrodeposition coating composition and electrodeposition coating method | 关西涂料株式会社 | 2023-05-02 | — | — | CN | disclosed |
| US-20170152232-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND | ASTELLAS PHARMA INC. (JP) | 2017-06-01 | — | — | US | disclosed |
| US-9464077-B2 | Nitrogen-containing aromatic heterocyclic compound | ASTELLAS PHARMA INC. (JP) | 2016-10-11 | — | — | US | disclosed |
| US-20140142084-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND | KOTOBUKI PHARMACEUTICAL CO., LTD. (JP) | 2014-05-22 | — | — | US | disclosed |
| US-6600080-B1 | Method of alcohols such as cyclohexanedimethanol, a benzyl ester is obtained, for example, by the reaction between a benzyl compound and carboxylic acid in the presence of oxygen and a catalyst including palladium, gold ultra fine particles | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-07-29 | — | — | US | disclosed |
| JP-2002003418-A | METHOD FOR PRODUCING ALICYCLIC OR AROMATIC ALCOHOL FROM ACETATE COMPOUND | NIPPON SHOKUBAI CO LTD | 2002-01-09 | — | — | JP | disclosed |
| JP-2001172212-A | METHOD FOR PRODUCING ALCOHOLS SUCH AS CYCLOHEXANEDIMETHANOL | NIPPON SHOKUBAI CO LTD | 2001-06-26 | — | — | JP | disclosed |
| EP-1090902-A2 | Method for producing alcohols such as cyclohexanedimethanol | Nippon Shokubai Co., Ltd. (JP) | 2001-04-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142084-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND | FGFR3, FGFR1, FGFR2 | LMNA 4621/4885ALDH1A1 1620/4885HSD17B10 2647/4885 |
| US-20170152232-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND | FGFR3, FGFR1, FGFR2 | LMNA 4565/4885ALDH1A1 1432/4885HSD17B10 2246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.